Antivirals Congress

Following the successful first Congress in Amsterdam, The Netherlands in 2010, the 2nd Antivirals Congress will be organized 11-13 November 2012 in Cambridge MA, USA. The key objectives of this interdisciplinary and unique congress are:

To provide a state-of-the-art report for scientists, health professionals and (non)governmental authorities
To accelerate progress in the development and application of antivirals: small molecules and biologics
To serve as an interface between different interest groups from academia, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals
The Congress will be supported by Antiviral Research, the most comprehensive and pre-eminent journal for those interested in the effective control of virus infections in animals and man as well as in plants or lower organisms.
+ show speakers and program
Confirmed Speakers

Raymond F. Schinazi, Emory University School of Medicine, USA
Patrick Kiser, University of Utah, USA
Jeffery K. Taubenberger, National Institutes of Health, USA
David R. Friend, CONRAD, USA
Teresa Compton, Biogen Idec, USA
Alan C. Jackson, University of Manitoba Health Sciences Centre, Canada
Subhash G. Vasudevan, Duke-NUS Graduate Medical School, Singapore (Co-Chair)
Julia Hilliard, Georgia State University, USA
Colleen B. Jonsson, Center for Predictive Medicine, USA
Sujan Shresta, La Jolla Institute for Allergy and Immunology, USA
Elena Govorkova, St. Jude Children’s Research Hospital, Memphis TN, USA
Warren Lee, University of Toronto, Canada
Ann Kwong, Vertex Pharmaceuticals, USA
Fabien Zoulim, INSERM, France
Giorgio Palù, University of Padova, Italy
Scott Weaver, Galveston National Laboratory, USA
Kai Lin, Novartis, USA
Tomas Cihlar, Gilead Sciences, USA
Thomas Hope, Northwestern University, Chicago, USA
Eric Verdin, UCSF, USA
Gustavo Doncel, Eastern Virginia Medical School, USA

11 Nov - 13 Nov 2012

United States of America
meeting website